Publikationen
| 1. | Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE). Shehata AM, Quintanilla-Fend L, Bettio S, Singh CB, Ammon HP
Phytomedicine. 2011 Sep;18(12):1037-44.
|
| 2. | BHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosis. Tripathi YB
Recent Pat Inflamm Allergy Drug Discov. 2009 Jan;3(1):49-57.
|
| 3. | A norsesquiterpene lactone and a benzoic acid derivative from the leaves of Cyclocarya paliurus and their glucosidase and glycogen phosphorylase inhibiting activities. Li J, Lu Y, Su X, Li F, She Z, He X, Lin Y
Planta Med. 2008 Feb;74(3):287-9.
|
| 4. | Hypoglycemic and other related effects of Boswellia glabra in alloxan-induced diabetic rats. Kavitha JV, Rosario JF, Chandran J, Anbu P
Indian J Physiol Pharmacol. 2007 Jan-Mar;51(1):29-39.
|
| 5. | Extract of gum resins of Boswellia serrata L. inhibits lipopolysaccharide induced nitric oxide production in rat macrophages along with hypolipidemic property. Pandey RS, Singh BK, Tripathi YB
Indian J Exp Biol. 2005 Jun;43(6):509-16.
|
| 6. | Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes. Altmann A, Poeckel D, Fischer L, Schubert-Zsilavecz M, Steinhilber D, Werz O
Br J Pharmacol. 2004 Jan;141(2):223-32.
|